We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sphere Medical | LSE:SPHR | London | Ordinary Share | GB00B551W951 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.40 | 0.35 | 0.45 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSPHR
RNS Number : 8872R
Sphere Medical Holding plc
15 December 2016
15 December 2016
Sphere Medical Holding plc
("Sphere", "Sphere Medical" or the "Company")
Appointment of Spanish Distributor
Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, is pleased to announce the appointment of Proyectos Hospitalarios Internacional S.A. ("Prhoinsa") as exclusive distributor of Proxima products in Spain. Prhoinsa is well established in Spain as a distributor of a variety of medical devices, including a number in the critical care arena.
Under the terms of the distribution agreement, Prhoinsa will commence marketing of Proxima in the second quarter of 2017 and has already placed initial orders for Proxima 4 monitors, launched in Europe yesterday, and consumables.
As announced on 21 July 2016, Sphere Medical has already appointed a distributor for Italy and the Company markets Proxima directly in the UK, Germany, Belgium and The Netherlands. The Company will continue to pursue the appointment of further regional distributors for Proxima in other European markets where not yet present.
Wolfgang Rencken, the Company's Chief Executive Officer, commented: "We are very pleased to appoint Prhoinsa as our distributor of Proxima in Spain and we look forward to expanding our geographical coverage further in the coming months, particularly now that Proxima 4 has been launched."
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
- Ends -
For further information, please contact:
Sphere Medical Holding Tel: +44 (0)1223 875 plc 222 Dr Wolfgang Rencken, Chief Executive Officer Richard Wright, Chief Financial Officer Panmure Gordon Tel: +44 (0) 20 7886 2500 Freddy Crossley (Corporate Finance) Duncan Monteith (Corporate Finance) Tom Salvesen (Corporate Broking) Consilium Strategic Tel: +44 (0) 20 3709 Communications 5700 Mary-Jane Elliott spheremedical@consilium-comms.com Ivar Milligan Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium and will be sold via distributors in Italy and Spain. For further information, please visit www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRFFAFWLFMSEEE
(END) Dow Jones Newswires
December 15, 2016 02:00 ET (07:00 GMT)
1 Year Sphere Medical Chart |
1 Month Sphere Medical Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions